The company said, “908 Devices (MASS) expects full year 2025 revenues from continuing operations of $53 million to $55 million, representing 11% to 15% growth compared to 2024 revenue from continuing operations. Full year 2025 reported revenues are expected to be $54 million to $56 million, inclusive of approximately $1 million of desktop revenues in the first quarter, prior to divestiture.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MASS:
- Repligen acquires bioprocessing analytic portfolio from 908 Devices for $70M
- Repligen purchases 908 Devices’ bioprocessng analytics portfolio for $70M
- Closing Bell Movers: Vericel down 11% after Q4 pre-announcement
- 908 Devices reports preliminary Q4 revenue $17.2M, consensus $16.2M
- 908 Devices sees FY24 revenue about $58M, consensus $57.0M